Insider Transactions in Q4 2021 at Windtree Therapeutics Inc (WINT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Bioengine Capital Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,239,088
-100.0%
|
$1,239,088
$1.6 P/Share
|
|
Dec 30
2021
|
Center Laboratories, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,239,088
+50.0%
|
$1,239,088
$1.6 P/Share
|
|
Nov 19
2021
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
930
+2.38%
|
$930
$1.6 P/Share
|
|
Nov 18
2021
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
930
+2.44%
|
$930
$1.61 P/Share
|
|
Oct 22
2021
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+7.63%
|
$3,000
$1.9 P/Share
|
|
Oct 19
2021
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+8.26%
|
$3,000
$1.91 P/Share
|
|
Oct 19
2021
|
James Huang Director |
BUY
Open market or private purchase
|
Direct |
50,000
+14.65%
|
$50,000
$1.9 P/Share
|